Clarivate Plc (CLVT) concluded trading on Wednesday at a closing price of $4.18, with 5.31 million shares of worth about $22.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.76% during that period and on May 07, 2025 the price saw a gain of about 0.24%. Currently the company’s common shares owned by public are about 683.10M shares, out of which, 387.60M shares are available for trading.
Stock saw a price change of -3.02% in past 5 days and over the past one month there was a price change of 24.04%. Year-to-date (YTD), CLVT shares are showing a performance of -17.72% which decreased to -38.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.04 but also hit the highest price of $7.30 during that period. The average intraday trading volume for Clarivate Plc shares is 6.78 million. The stock is currently trading 12.46% above its 20-day simple moving average (SMA20), while that difference is up 6.58% for SMA50 and it goes to -22.23% lower than SMA200.
Clarivate Plc (NYSE: CLVT) currently have 683.10M outstanding shares and institutions hold larger chunk of about 67.41% of that.
The stock has a current market capitalization of $2.86B and its 3Y-monthly beta is at 1.51. It has posted earnings per share of -$0.98 in the same period. It has Quick Ratio of 0.88 while making debt-to-equity ratio of 0.91. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLVT, volatility over the week remained 3.57% while standing at 6.85% over the month.
Stock’s fiscal year EPS is expected to drop by -11.93% while it is estimated to increase by 7.48% in next year. EPS is likely to grow at an annualized rate of 2.63% for next 5-years, compared to annual growth of -0.40% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Clarivate Plc (CLVT) stock as an Underweight in their note to investors on December 15, 2023, suggesting a price target of $8 for the stock. On October 16, 2023, Jefferies Upgrade their recommendations, while on September 08, 2023, Barclays Downgrade their ratings for the stock with a price target of $7. Stock get a Sector perform rating from RBC Capital Mkts on August 25, 2023.
